Ken Harvey attended Medicines Australia (MA) Code revision workshop as a representative of CHOICE but declined remuneration from MA for his time. He has been involved in prior MA Code revisions and ...
Posts online have raised concern over the use of the word “poison” in Western Australian legislation that has authorised the COVID-19 vaccine. However, poison is a generic legal term in Australia and ...
Talks of a trade dispute between the United States and Australia over the cost of medicines have no doubt left many Australians scratching their heads. With all this talk of attacks on the ...
The Australian government delivered an early Christmas present to the biopharma industry in the form of a new National Medicines Policy giving voice to major industry goals – among them a clear vision ...
About 400 medicines are in short supply in Australia. Of these, about 30 are categorised as critical. These are ones with a life-threatening or serious impact on patients, and with no readily ...
The United States pharmaceutical lobby has complained to US President Donald Trump that Australia’s Pharmaceutical Benefits Scheme (PBS) is damaging their profits and has urged Trump to put tariffs on ...
Simon Quilty does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...
Anthony Albanese's government is declaring Australia will not buckle to pressure from US drug companies to scrap Pharmaceutical Benefits Scheme subsidies, even with the threat of new tariffs. Despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback